Publication Name	World Journal of Gastrointestinal Surgery
Manuscript ID	89833
Country	China

Received	2023-11-14 07:05
Peer-Review Started	2023-11-14 07:06
To Make the First Decision
Return for Revision	2023-12-08 06:48
Revised	2023-12-19 01:55
Second Decision	2023-12-29 02:43
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2023-12-29 05:32
Articles in Press	2023-12-29 05:32
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-01-19 05:09
Publish the Manuscript Online	2024-01-25 06:43

ISSN	1948-9366 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Meta-Analysis
Article Title	Role of Oncostatin M in the prognosis of inflammatory bowel disease: A meta-analysis
Manuscript Source	Unsolicited Manuscript
All Author List	Yue Yang, Kan-Zuo Fu and Gu Pan
ORCID	Author(s) ORCID Number Gu Pan http://orcid.org/0009-0009-9248-5714
Funding Agency and Grant Number
Corresponding Author	Gu Pan, BSc, Nurse, Department of Gastroenterology III, Heilongjiang Provincial Hospital, No. 405 Guogoli Street, Nangang District, Harbin 150036, Heilongjiang Province, China. pangu6196@126.com
Key Words	Inflammatory bowel disease; Crohn’s disease; Ulcerative colitis; Oncostatin M; Prognosis
Core Tip	Higher Oncostatin M (OSM) expression/levels are found to be associated with worse disease outcomes which shows that OSM can be used as a s surrogate marker of poor prognosis in inflammatory bowel disease patients treated with anti-tumor necrosis factor based therapies. Thus, OSM appears to be an attractive biomarker for patient selection and clinical decision-making. However, owing to the presence of heterogeneity in included studies, this evidence should be refined in future studies.
Publish Date	2024-01-25 06:43
Citation	Yang Y, Fu KZ, Pan G. Role of Oncostatin M in the prognosis of inflammatory bowel disease: A meta-analysis. World J Gastrointest Surg 2024; 16(1): 228-238
URL	https://www.wjgnet.com/1948-9366/full/v16/i1/228.htm
DOI	https://dx.doi.org/10.4240/wjgs.v16.i1.228

Full Article (PDF)	WJGS-16-228-with-cover.pdf
Full Article (Word)	WJGS-16-228.docx
PRISMA 2009 Checklist	89833-PRISMA 2009 checklist.pdf
Manuscript File	89833_Auto_Edited-YJP.docx
Answering Reviewers	89833-Answering reviewers.pdf
Audio Core Tip	89833-Audio core tip.mp3
Biostatistics Review Certificate	89833-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form	89833-Conflict-of-interest statement.pdf
Copyright License Agreement	89833-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	89833-Language certificate.pdf
Supplementary Material	89833-Supplementary material.pdf
Peer-review Report	89833-Peer-review(s).pdf
Scientific Misconduct Check	89833-Bing-Gong ZM-2.png
Scientific Misconduct Check	89833-CrossCheck.png
Scientific Editor Work List	89833-Scientific editor work list.pdf